Cargando…
Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer
The treatment of colorectal cancer (CRC) might be improved by the identification of a signalling pathway that could be targeted with novel therapeutics. The results of this study indicate that the taurine transporter SLC6A6 is highly expressed in CRC cells compared with normal colonocytes. SLC6A6 kn...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004982/ https://www.ncbi.nlm.nih.gov/pubmed/24781822 http://dx.doi.org/10.1038/srep04852 |